Effect of treatment with sitagliptin on somatosensory-evoked potentials and metabolic control in patients with type 2 diabetes mellitus

Prescription patterns for diabetes mellitus and therapeutic implications: a population-based analysis

(2017) Camilo Molino Guidoni et al.   Arquivos Brasileiros de Endocrinologia e Metabologia

Effects of sitagliptin beyond glycemic control: focus on quality of life

(2013) Yoshiko Sakamoto et al.   Cardiovascular Diabetology

Neuroprotective effect of the glucagon-like peptide-1 receptor agonist, synthetic exendin-4, in streptozotocin-induced diabetic rats

(2011) Wei Jing Liu et al.   BRITISH JOURNAL OF PHARMACOLOGY

Beneficial Effects of Exendin-4 on Experimental Polyneuropathy in Diabetic Mice

(2011) T. Himeno et al.   DIABETES

GLP-1 signals via ERK in peripheral nerve and prevents nerve dysfunction in diabetic mice

(2011) C. G. Jolivalt et al.   DIABETES OBESITY & METABOLISM

Effect of Dipeptidyl Peptidase-IV (DPP-IV) Inhibitor (Vildagliptin) on Peripheral Nerves in Streptozotocin-induced Diabetic Rats

(2009) Heung Yong Jin et al.   ARCHIVES OF MEDICAL RESEARCH

Elevated Triglycerides Correlate With Progression of Diabetic Neuropathy

(2009) T. D. Wiggin et al.   DIABETES

Standards of Medical Care in Diabetes--2010

(2009)   DIABETES CARE